Similar articles

• Albuminuria and cardiovascular risk: time for a new direction?

  Charytan DM. Charytan DM. Clin J Am Soc Nephrol. 2011 Jun;6(6):1235-7. doi: 10.2215/CJN.03630411. Epub 2011 May 19. Clin J Am Soc Nephrol. 2011. PMID: 21597027 No abstract available.
• [Chronic kidney disease. Better detect, slow its progression and cardiovascular risk, prepare for renal replacement therapy].

  Legendre C. Legendre C. Rev Prat. 2012 Jan;62(1):27-9. Rev Prat. 2012. PMID: 22335062 French. No abstract available.
• [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].

  Ratto E, Leoncini G, Viazzi F, Pontremoli R. Ratto E, et al. G Ital Nefrol. 2008 Jan-Feb;25(1):21-31. G Ital Nefrol. 2008. PMID: 18264915 Review. Italian.
• Chronic kidney disease as cause of cardiovascular morbidity and mortality.

  Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N; European Uremic Toxin Work Group. Vanholder R, et al. Nephrol Dial Transplant. 2005 Jun;20(6):1048-56. doi: 10.1093/ndt/gfh813. Epub 2005 Apr 6. Nephrol Dial Transplant. 2005. PMID: 15814534 Review.
• The epidemic challenge of chronic kidney disease in older patients.

  Abdelhafiz AH, Tan E, El Nahas M. Abdelhafiz AH, et al. Postgrad Med. 2008 Nov;120(4):87-94. doi: 10.3810/pgm.2008.11.1943. Postgrad Med. 2008. PMID: 19020370 Review.